相关实验视频
Updated: May 16, 2025

07:20
Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
9.8K
专题综述:阿特罗宾对近视控制的潜在机制
Darryl Horn1, Aaron D Salzano2, Erin C Jenewein1
1Pennsylvania College of Optometry, Salus at Drexel University, Elkins Park, Pennsylvania.
概括
氨酸有效地减缓了儿童近视的进展,尽管它的确切机制尚不清楚. 研究表明,多个受体通路,而不仅仅是肌肉性受体,有助于抑制眼睛的生长.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 近视 (近视) 是一个日益严重的全球健康问题,与严重的眼睛疾病有关.
- 氨酸是儿童近视控制的关键治疗方法,有效性因度而异.
- 阿特罗宾抑制近视进展的精确分子机制仍在研究中.
研究的目的:
- 审查关于阿特罗宾近视控制作用的基于受体的机制的证据.
- 探索氨酸如何与各种眼睛受体相互作用以减缓近视的进展.
- 综合目前对阿特罗宾在抑制眼睛生长中的多方面作用的理解.
主要方法:
- 基于证据的科学文献审查.
- 对阿特罗宾对眼睛受体通路的影响研究的分析.
- 关于近视控制的动物和人类研究结果的综合.
主要成果:
- 氨酸对近视的作用可能超出肌类受体.
- 有证据表明,氨酸与多巴胺,上腺体,GABA和细胞因子受体相互作用.
- 多个受体通路可能有助于阿特罗宾的近视控制作用.
结论:
- 氨酸可能通过直接和间接机制的结合来抑制近视的进展.
- 在近视控制中,阿特罗宾的单一作用模式不太可能.
- 氨酸对多个眼组织水平的影响,共同抑制眼睛生长和近视.
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.0K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.1K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.1K
Open Angle Glaucoma: Treatment
368
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
368
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
579
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
579
Direct-Acting Cholinergic Agonists: Therapeutic Uses
646
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
646
Cholinergic Antagonists: Pharmacological Actions
743
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
743

